We are live on ! Find out more
ALXO icon

ALX Oncology

108 hedge funds and large institutions have $780M invested in ALX Oncology in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 22 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 22

4.07% more ownership

Funds ownership: 85.54% → 89.61% (+4.1%)

9% more capital inflows, than outflows

Capital inflows: $200M | Capital outflows: $183M

5% less funds holding

Funds holding: 114 → 108 (-6)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

25% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 36

48% less call options, than puts

Call options by funds: $262K | Put options by funds: $503K

Holders
108
Holders Change
-6
Holders Change %
-5.26%
% of All Funds
1.66%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
27
Increased
36
Reduced
22
Closed
36
Calls
$262​K
Puts
$503​K
Net Calls
-⁠$241​K
Net Calls Change
-⁠$4.17​M

ALXO Hedge Fund Activity: Q4 2021 in Review

108 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in ALX Oncology (ALXO) for Q4 2021, worth a combined $780M — down 69% from $2.55B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of ALXO and 27 opened new positions — a net loss of 9 holders — while 22 trimmed existing stakes and 36 added.

The largest buyer was Fidelity Investments, adding an estimated $57.5M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $41.1M sold.

  • 108 institutional investors held ALX Oncology (ALXO) as of Q4 2021, down from 114 in Q3 2021.
  • Funds reported $780M of ALX Oncology stock for Q4 2021, down 69% quarter-over-quarter.
  • 27 funds opened new ALX Oncology positions in Q4 2021 and 36 closed out, a net change of -9 holders.
  • The largest ALX Oncology buyer in Q4 2021 was Fidelity Investments, an estimated $57.5M added.
  • The largest ALX Oncology seller in Q4 2021 was Lord, Abbett & Co, an estimated $41.1M sold.

Based on aggregated 13F filings for Q4 2021.